No Racial Disparities in CVD Outcomes For VA Patients with Prostate Cancer Receiving ADTMarch 11, 2025Prostate Cancer
Service Connection Expanded to Additional CancersJanuary 31, 2025Prostate CancerLeukemia, Myelodysplasia, TransplantationMultiple MyelomaGenitourinary Cancer
VA Study Asks: Has Active Surveillance Solved the Problem of Overtreatment? January 28, 2025Prostate CancerOncologyGenitourinary Cancer
Transgender Women and Prostate Cancer: It’s ComplicatedSeptember 23, 2024Prostate CancerGenitourinary CancerOncology
The OCTAGON Project: A Novel VA-Based Telehealth Intervention for Oral Chemotherapy MonitoringSeptember 12, 2024Prostate CancerOncologyLung CancerLymphoma & Plasma Cell Disorders
Implementing a Prospective Surveillance Physical Therapy Program for Those Affected by CancerSeptember 11, 2024Prostate CancerOncology
Whole Health Oncology—Just Do It: Making Whole Person Cancer Care Routine and Regular at the Dayton VA Medical Center (DVAMC)September 11, 2024Prostate CancerOncologyBreast Cancer
A Phase II Study With Androgen Deprivation Therapy and Up-Front Radiotherapy in High-Intermediate and High-Risk Prostate Cancer With Stereotactic Body Radiation Therapy to Pelvic Nodes and Concomitant Prostate Boost by Simultaneous Integrated BoostSeptember 6, 2024Prostate CancerOncology
Do We Need More Screen Time? Patterns of Telehealth Utilization for Patients With Prostate Cancer in the Veterans Health Administration (VHA)September 5, 2024Prostate CancerOncology
Metastatic Prostate Cancer Presenting as Pleural and Pericardial Metastases: A Case Report and Literature ReviewSeptember 5, 2024Prostate CancerOncology
Creating a Urology Prostate Cancer Note, a National Oncology and Surgery Office Collaboration for Prostate Cancer Clinical Pathway UtilizationAugust 30, 2024Prostate CancerOncology
